Literature DB >> 29484719

Lipase-Triggered Water-Responsive "Pandora's Box" for Cancer Therapy: Toward Induced Neighboring Effect and Enhanced Drug Penetration.

Cheng Wang1, Shaoqing Chen1, Yunxin Wang1, Xuerong Liu1, Fuqiang Hu1, Jihong Sun2, Hong Yuan1.   

Abstract

Insufficient drug release as well as poor drug penetration are major obstacles for effective nanoparticles (NPs)-based cancer therapy. Herein, the high aqueous instability of amorphous calcium carbonate (ACC) is employed to construct doxorubicin (DOX) preloaded and monostearin (MS) coated "Pandora's box" (MS/ACC-DOX) NPs for lipase-triggered water-responsive drug release in lipase-overexpressed tumor tissue to induce a neighboring effect and enhance drug penetration. MS as a solid lipid can prevent potential drug leakage of ACC-DOX NPs during the circulatory process, while it can be readily be disintegrated in lipase-overexpressed SKOV3 cells to expose the ACC-DOX core. The high aqueous instability of ACC will lead to burst release of the encapsulated DOX to induce apoptosis and cytotoxicity to kill the tumor cells. The liberated NPs from the dead or dying cells continue to respond to the ubiquitous aqueous environment to sufficiently release DOX once unpacked, like the "Pandora's box", leading to severe cytotoxicity to neighboring cells (neighboring effect). Moreover, the continuously released free DOX molecules can readily diffused through the tumor extracellular matrix to enhance drug penetration to deep tumor tissue. Both effects contribute to achieve elevated antitumor benefits.
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  amorphous calcium carbonate; drug penetration; lipase; neighboring effect; water-responsive

Mesh:

Substances:

Year:  2018        PMID: 29484719     DOI: 10.1002/adma.201706407

Source DB:  PubMed          Journal:  Adv Mater        ISSN: 0935-9648            Impact factor:   30.849


  28 in total

1.  Ultrasound Combined with Core Cross-Linked Nanosystem for Enhancing Penetration of Doxorubicin Prodrug/Beta-Lapachone into Tumors.

Authors:  Qianyan Li; Wei Hou; Meixuan Li; Hemin Ye; Huanan Li; Zhibiao Wang
Journal:  Int J Nanomedicine       Date:  2020-07-07

2.  Biodegradable pH-responsive amorphous calcium carbonate nanoparticles as immunoadjuvants for multimodal imaging and enhanced photoimmunotherapy.

Authors:  Meng Wang; Benqing Zhou; Lu Wang; Feifan Zhou; Nataliya Smith; Debra Saunders; Rheal A Towner; Jun Song; Junle Qu; Wei R Chen
Journal:  J Mater Chem B       Date:  2020-09-23       Impact factor: 6.331

3.  Multifunctional nanobubbles carrying indocyanine green and paclitaxel for molecular imaging and the treatment of prostate cancer.

Authors:  Minmin Lan; Lianhua Zhu; Yixuan Wang; Daijia Shen; Kejing Fang; Yu Liu; Yanli Peng; Bin Qiao; Yanli Guo
Journal:  J Nanobiotechnology       Date:  2020-09-03       Impact factor: 10.435

4.  MicroRNA-382 inhibits cell growth and migration in colorectal cancer by targeting SP1.

Authors:  Yupeng Ren; Hao Zhang; Peng Jiang
Journal:  Biol Res       Date:  2018-11-24       Impact factor: 5.612

5.  Quercetin and doxorubicin co-delivery using mesoporous silica nanoparticles enhance the efficacy of gastric carcinoma chemotherapy.

Authors:  Jian Fang; Shangwu Zhang; Xiaofeng Xue; Xinguo Zhu; Shiduo Song; Bin Wang; Linhua Jiang; Mingde Qin; Hansi Liang; Ling Gao
Journal:  Int J Nanomedicine       Date:  2018-09-06

6.  Silk Fibroin-Coated Nanoagents for Acidic Lysosome Targeting by a Functional Preservation Strategy in Cancer Chemotherapy.

Authors:  Mixiao Tan; Weiwei Liu; Fengqiu Liu; Wei Zhang; Hui Gao; Juan Cheng; Yu Chen; Zhigang Wang; Yang Cao; Haitao Ran
Journal:  Theranostics       Date:  2019-01-25       Impact factor: 11.556

7.  miRNA-99b-5p targets FZD8 to inhibit non-small cell lung cancer proliferation, migration and invasion.

Authors:  Rui Liu; Yajuan Chen; Tao Shou; Jing Hu; Chen Qing
Journal:  Onco Targets Ther       Date:  2019-04-08       Impact factor: 4.147

8.  Mitoxantrone-preloaded water-responsive phospholipid-amorphous calcium carbonate hybrid nanoparticles for targeted and effective cancer therapy.

Authors:  Cheng Wang; Min Han; Xuerong Liu; Shaoqing Chen; Fuqiang Hu; Jihong Sun; Hong Yuan
Journal:  Int J Nanomedicine       Date:  2019-02-25

9.  Nanostructured lipid carriers co-delivering lapachone and doxorubicin for overcoming multidrug resistance in breast cancer therapy.

Authors:  Xin Li; Xiaoqian Jia; Hu Niu
Journal:  Int J Nanomedicine       Date:  2018-07-12

10.  Calcium Supplement by Tetracycline guided amorphous Calcium Carbonate potentiates Osteoblast promotion for Synergetic Osteoporosis Therapy.

Authors:  Jianwei Wang; Shan Tao; Xiangyu Jin; Yanqing Song; Wentao Zhou; Haiya Lou; Rui Zhao; Cheng Wang; Fuqiang Hu; Hong Yuan
Journal:  Theranostics       Date:  2020-07-09       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.